Teladoc Health, Inc. (TDOC) Stock Overview
Explore Teladoc Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Teladoc Health, Inc. (TDOC)
Key Financials
Key Financials
Market Cap
1.6B
P/E Ratio
-9.19
EPS (TTM)
$-0.90
ROE
-0.12%
TDOC Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Teladoc Health, Inc. (NYSE: TDOC) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Teladoc Health, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TDOC on the NYSE shows an RSI of 50.72, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.57 for the NYSE listing.
Key metrics behind Teladoc Health, Inc.'s NYSE-traded stock include a P/E ratio of -9.19 and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TDOC on the NYSE.